Elevated Vigor. Visible Refinement.
Wegovy® (Semaglutide) Injection — Once-Weekly Weight-Loss Autoinjector
Price range: $199.00 through $399.00
Extra Features
- Dermatologist Approved
- Secure Payments
- Satisfaction Guarantee
- Worldwide Shipping
- Money Back Guarantee
Chronic weight management · Adults + adolescents 12+ · Subcutaneous autoinjector
Wegovy® 0.25 mg — The Opening Chapter of Your Weight-Loss Story
Once-weekly autoinjector · Month 1 of 16-week escalation.
Wegovy® 0.5 mg — Building Momentum, Week by Week
Once-weekly autoinjector · Month 2 of escalation
Wegovy® 1 mg — Halfway Up the Escalation Ladder
Once-weekly autoinjector · Month 3 of escalation
Wegovy® 1.7 mg — The Final Climb Before Full Strength
Once-weekly autoinjector · Month 4 of escalation
Wegovy® 2.4 mg — The Summit Dose for Sustained Weight Loss
Once-weekly autoinjector · Full maintenance dose
Month one. A carefully calibrated start designed to ease your system in — the transformative results build from here.
Wegovy® 0.25 mg semaglutide is the first-month initiation dose in the structured 16-week Wegovy escalation protocol. The autoinjector simplifies once-weekly self-administration as the body acclimates to GLP-1 agonism for chronic weight management in adults and adolescents.
Weeks five through eight. Hunger signals begin softening as the dose climbs the escalation ladder toward full strength.
Wegovy® 0.5 mg semaglutide continues the structured dose-escalation period in the second month of therapy. Once-weekly subcutaneous injection maintains consistent semaglutide plasma levels during the titration phase for chronic weight management.
The midpoint of the escalation journey. Appetite suppression becomes noticeably more sustained, and weight loss starts gaining real momentum.
Wegovy® 1 mg semaglutide is the third step of the four-rung titration protocol. The once-weekly autoinjector continues building toward full maintenance dosing while the body progressively adapts to elevated GLP-1 receptor stimulation for chronic weight management.
One step from the summit. Robust appetite reduction and meaningful weight loss are now fully underway — the 2.4 mg maintenance dose is within reach.
Wegovy® 1.7 mg semaglutide is the penultimate escalation dose, administered once weekly during weeks 13–16 of therapy. This step ensures optimal tolerability before advancing to the 2.4 mg long-term maintenance dose for obesity management.
The full maintenance dose. In the STEP trials, the average patient lost over 15% of body weight — one weekly autoinjector maintaining peak GLP-1 activity.
Wegovy® 2.4 mg semaglutide is the FDA-approved maintenance dose for chronic weight management in adults with obesity or overweight with a weight-related comorbidity. The once-weekly autoinjector delivers the highest approved semaglutide dose, producing an average 15–17% body weight reduction in the landmark STEP clinical trials.
| Dosage | 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg |
|---|
Be the first to review “Wegovy® (Semaglutide) Injection — Once-Weekly Weight-Loss Autoinjector”
Related products
-
Ozempic® (Semaglutide) Injection — Once-Weekly Pre-Filled Pen
Price range: $189.00 through $359.00 Select options This product has multiple variants. The options may be chosen on the product page -
Zepbound® (Tirzepatide) Injection — Once-Weekly Weight-Loss Dual-Action Pen
Price range: $299.00 through $589.00 Select options This product has multiple variants. The options may be chosen on the product page -
Mounjaro® (Tirzepatide) Injection — Once-Weekly Dual-Action Pen
Price range: $199.00 through $400.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.